Management of Cancer Treatment–Related Diarrhea: Issues and Therapeutic Strategies

The cancer treatment–related diarrhea caused by acute graft-versus-host disease (GVHD) and chemotherapeutic agents, particularly fluoropyrimidines and irinotecan, significantly affects patient morbidity and mortality. The mechanisms causing cancer treatment–related diarrhea are not fully understood,...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of pain and symptom management 2000-02, Vol.19 (2), p.118-129
Hauptverfasser:	Kornblau, Steven, Al B. Benson, Catalano, Robert, Champlin, Richard E., Engelking, Constance, Field, Michael, Ippoliti, Cindy, Lazarus, Hillard M., Mitchell, Edith, Rubin, Joseph, Stiff, Patrick J., Vokes, Everett, Wadler, Scott
Format:	Artikel
Sprache:	eng
Schlagworte:	Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Antineoplastic Agents - adverse effects Biological and medical sciences Bone marrow transplant Bone marrow, stem cells transplantation. Graft versus host reaction diarrhea Diarrhea - chemically induced Diarrhea - drug therapy Diarrhea - etiology Drug toxicity and drugs side effects treatment fluoropyrimidines Graft vs Host Disease - complications graft-versus-host disease Humans irinotecan Medical sciences Neoplasms - therapy octreotide Pharmacology. Drug treatments Practice Guidelines as Topic Toxicity: digestive system Transfusions. Complications. Transfusion reactions. Cell and gene therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!